Bracebridge Capital, LLC - Q4 2020 holdings

$658 Million is the total value of Bracebridge Capital, LLC's 14 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 53.8% .

 Value Shares↓ Weighting
BuyISHARES TRcall$414,675,000
+22.8%
47,500
+18.0%
62.99%
+16.5%
NewISHARES TRput$130,950,00015,000
+100.0%
19.89%
 LIBERTY MEDIA CORPdeb$36,760,000
+3.5%
47,700,0000.0%5.58%
-1.8%
 DISH NETWORK CORPORATIONnote$16,859,000
+2.1%
17,800,0000.0%2.56%
-3.1%
DISH  DISH NETWORK CORPORATIONcl a$11,301,000
+11.4%
349,4310.0%1.72%
+5.7%
NewQUANTUMSCAPE CORPput$8,251,000977
+100.0%
1.25%
 LIBERTY MEDIA CORPdeb$7,237,000
+4.0%
9,500,0000.0%1.10%
-1.3%
NewPERSHING SQUARE TONTINE HLDGput$6,852,0002,472
+100.0%
1.04%
AMBC BuyAMBAC FINL GROUP INC$6,547,000
+157.2%
425,704
+113.6%
0.99%
+143.6%
NLSN  NIELSEN HOLDINGS$6,261,000
+47.2%
300,0000.0%0.95%
+39.6%
 TEVA PHARMACEUTICAL FIN LLCdbcv$5,390,000
+1.0%
5,500,0000.0%0.82%
-4.1%
QSWS NewQUANTUMSCAPE CORPw exp 11/25/202$3,713,00097,700
+100.0%
0.56%
AQST  AQUESTIVE THERAPEUTICS INC$2,293,000
+10.1%
428,5710.0%0.35%
+4.2%
CCO  CLEAR CHANNEL OUTDOOR HLDGS$1,248,000
+65.1%
756,4260.0%0.19%
+57.0%
ExitDINE BRANDS GLOBAL INCput$0-300
-100.0%
-0.26%
ExitISHARES TRcall$0-3,900
-100.0%
-9.36%
ExitISHARES TR$0-17,000
-100.0%
-22.84%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-02-16
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
LIBERTY MEDIA CORP DEL16Q3 202310.0%
AMBAC FINL GROUP INC16Q3 20236.2%
AQUESTIVE THERAPEUTICS INC16Q3 20230.6%
CLEAR CHANNEL OUTDOOR HLDGS16Q3 20230.6%
DISH NETWORK CORPORATION11Q2 20225.5%
ISHARES TR10Q3 202365.7%
ISHARES TR10Q3 202372.3%
COMPUTE HEALTH ACQUISITIN CO10Q2 20230.6%
CHURCHILL CAPITAL CORP VII9Q1 20230.3%
CHURCHILL CAPITAL CORP VI9Q1 20230.1%

View Bracebridge Capital, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
Bracebridge Capital, LLC Q4 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Quotient LtdFebruary 22, 202362,0300.3%
Clarus Therapeutics Holdings, Inc.July 06, 20221,461,8222.8%
PERNIX THERAPEUTICS HOLDINGS, INC.Sold outMay 26, 201600.0%

View Bracebridge Capital, LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-12
SC 13G/A2024-02-08
SC 13D/A2023-11-17
42023-11-16
13F-HR2023-11-14
SC 13D/A2023-08-25
13F-HR2023-08-14
42023-08-04
SC 13D2023-06-16
SC 13G2023-06-15

View Bracebridge Capital, LLC's complete filings history.

Compare quarters

Export Bracebridge Capital, LLC's holdings